ANTIBODY THAT RECOGNIZES PHOSPHORYLATED SMURF2, CANCER DIAGNOSIS AGENT CONTAINING THE ANTIBODY, AND SCREENING METHOD FOR CANCER THERAPEUTIC AGENT WITH THE ANTIBODY

PROBLEM TO BE SOLVED: To provide an antibody that can diagnose cancer.SOLUTION: It is found out that the level (strength) of phosphorylation of threonine at 249th from the N terminal of Smurf2 protein, is different in cancer tissue from in normal tissue.SELECTED DRAWING: None 【課題】癌を診断できる抗体を提供することを解決...

Full description

Saved in:
Bibliographic Details
Main Author HII EIICHI
Format Patent
LanguageEnglish
Japanese
Published 29.11.2018
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide an antibody that can diagnose cancer.SOLUTION: It is found out that the level (strength) of phosphorylation of threonine at 249th from the N terminal of Smurf2 protein, is different in cancer tissue from in normal tissue.SELECTED DRAWING: None 【課題】癌を診断できる抗体を提供することを解決すべき課題とした。【解決手段】Ｓｍｕｒｆ２タンパク質のＮ末端から２４９番目のスレオニンのリン酸化の程度（強度）が、癌組織において、正常組織に比べて異なることを見出したことにより、本発明を完成した。【選択図】なし
Bibliography:Application Number: JP20170092898